<?xml version="1.0" encoding="UTF-8"?>
<p id="para270">As a myriad of process and technological opportunities exists, we asked subject matter experts to prioritise investment in various opportunities on the basis of the breadth of applicability and market readiness. For the global health community to prioritise investment, we propose that the high-impact, pathogen-agnostic, and low-risk opportunities should be considered as priorities for near-term initiatives, and that pathogen-agnostic and high-risk opportunities should be considered as priorities for the medium term (
 <xref rid="fig1" ref-type="fig">figure</xref> ).
</p>
